Functional studies of membrane-bound and purified human Hedgehog receptor Patched expressed in yeast

Olivier Joubert1, Rony Nehmé, Damien Fleury

  • 1Laboratoire de Biologie et de Physiopathologie des Systèmes Intégrés, CNRS FRE 3094, Faculté des Sciences, (Université de Nice - Sophia Antipolis), Parc Valrose, F-06108 Nice Cedex 2, France.

Insights

Researchers expressed human Patched (hPtc) in yeast, achieving its native conformation for interaction with Sonic Hedgehog (Shh). This breakthrough enables large-scale hPtc production for studying Shh pathway dysfunction in diseases.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Developmental Biology

Background:

  • The Sonic Hedgehog (Shh) pathway is crucial for embryonic development and stem cell function.
  • Dysregulation of Shh signalling, involving Patched (Ptc) and Smoothened (Smo) receptors, is linked to birth defects, cancer, and neurodegenerative diseases.
  • Understanding Ptc's interaction with Smo is vital, but limited knowledge exists regarding Ptc's structure and function.

Purpose of the Study:

  • To develop structure-function studies of the Shh pathway receptors, Ptc and Smo.
  • To achieve heterologous expression and purification of human Ptc (hPtc) in a native conformation.
  • To enable biochemical characterization of hPtc for therapeutic development.

Main Methods:

  • Heterologous expression of human Ptc (hPtc) in Saccharomyces cerevisiae.
  • Interaction studies of hPtc with purified Sonic Hedgehog (Shh) ligand in yeast membrane fractions.
  • Surface Plasmon Resonance (SPR) technology to assess ligand-binding capabilities after purification using fluorinated surfactants.

Main Results:

  • Successfully expressed functional human Ptc (hPtc) in yeast, maintaining its native conformation.
  • Demonstrated that yeast-expressed hPtc interacts with its ligand, Shh.
  • Confirmed that fluorinated surfactants preserve hPtc's ligand-binding ability post-purification.

Conclusions:

  • This study reports the first successful heterologous expression and purification of a stable, native conformation of human Ptc.
  • The developed method allows for the scale-up of hPtc production for comprehensive biochemical characterization.
  • This work paves the way for developing novel therapeutics targeting Shh signalling pathway dysfunctions.